Back to results
US 2014/0227236 A1Published application
Hiv-resistant stem cells and uses thereof
AssigneeStemCyte, Inc.
InventorWise Young
Life of this patent
Estimating the term…
Abstract
Disclosed are recombinant stem cells that are resistant to HIV infection. Also disclosed are their uses in treating AIDS.
Claims8
A method for treating a human subject having, or at risk of having, an HIV infection, the method comprising obtaining human umbilical cord blood cells containing a first RNAi agent that represses the expression of CCR5 and a second RNAi agent that represses the expression of CXCR4;
- administering to a human subject in need thereof an effective amount of the umbilical cord blood cells.
An isolated human umbilical cord blood cell that contains a first RNAi agent that represses the expression of CCR5 and a second RNAi agent that represses the expression of CXCR4.
8-9. (canceled)
Dependencies are inferred from the claim text.